https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-762009-09-29 00:00:002019-02-15 08:36:11Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-22 / Mol. Ther. 2009 Dec;17(12):2049-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-22 / Mol. Ther. 2009 Dec;17(12):2049-572009-09-22 00:00:002019-02-15 08:48:18Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-15 / Exp. Dermatol. 2010 Feb;19(2):108-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-15 / Exp. Dermatol. 2010 Feb;19(2):108-162009-09-15 00:00:002019-02-15 08:48:17Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-572009-09-13 00:00:002019-02-15 08:34:56Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-08 / Mol. Ther. 2010 Feb;18(2):264-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-08 / Mol. Ther. 2010 Feb;18(2):264-742009-09-08 00:00:002019-02-15 08:44:16Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-01 / J BUON 2009 Sep;14 Suppl 1:S111-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-01 / J BUON 2009 Sep;14 Suppl 1:S111-222009-09-01 00:00:002021-11-15 17:00:58Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-01 / Prostate 2009 Sep;69(12):1343-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-01 / Prostate 2009 Sep;69(12):1343-522009-09-01 00:00:002019-02-15 08:48:19Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-01 / Int. J. Oncol. 2009 Sep;35(3):569-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-01 / Int. J. Oncol. 2009 Sep;35(3):569-812009-09-01 00:00:002019-02-15 08:48:08Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-01 / Ann. N. Y. Acad. Sci. 2009 Sep;1174:18-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-01 / Ann. N. Y. Acad. Sci. 2009 Sep;1174:18-232009-09-01 00:00:002019-02-15 08:59:38Brain tumor immunotherapy with type-1 polarizing strategies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-01 / Ann. N. Y. Acad. Sci. 2009 Sep;1174:41-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-01 / Ann. N. Y. Acad. Sci. 2009 Sep;1174:41-502009-09-01 00:00:002019-02-15 08:44:15Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers